In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...
Merck has invested in digital infrastructure and tools in the past five years; we are now focused on building and scaling an innovation engine that harnesses the power of data and digital to ...
Merck & Co has announced the US launch of a mobile app designed to help and enhance communications between diabetes patients and educators. US-based Merck said the app known as map4health was ...
UnitedHealth's shares are down $8.97 (1.8%) while those of Merck are down $1.98 (1.6%), combining for a roughly 72-point drag on the Dow. Nike Amgen and IBM are also contributing significantly to ...
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...
Shares of Microsoft and Merck are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and ...
Merck's shares are up $6.34, or 5.1%, while those of Intel are up $1.56 (3.7%), combining for a roughly 52-point boost for the Dow. Caterpillar Apple and Boeing are also contributing significantly ...
(Reuters) - Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of ...
International science and technology firm Merck has announced investment of over £4 million in its Life Science facility in Livingston, bringing new jobs to the town. Did you know with a Digital ...
Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...
Shares of Microsoft and Merck are trading lower Thursday morning, sending the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and FactSet ...
We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...